Recommended Reading on Thrombosis

From the ESC Working Group on Thrombosis

Date

Title

• Date: 21/04/2025
  Title: Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
• Date: 21/04/2025
  Title: Interplay between platelets and coagulation: from protective haemostasis to pathological arterial thrombosis
• Date: 21/04/2025
  Title: Evolution of left ventricular thrombus on serial cardiovascular magnetic resonance imaging
• Date: 01/02/2025
  Title: Doubts over landmark heart drug trial: ticagrelor PLATO study
• Date: 01/02/2025
  Title: The humanized platelet glycoprotein VI Fab inhibitor EMA601 protects from arterial thrombosis and ischaemic stroke in mice
• Date: 01/02/2025
  Title: Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials
• Date: 01/12/2024
  Title: Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial
• Date: 01/12/2024
  Title: Asundexian versus Apixaban in Patients with Atrial Fibrillation
• Date: 01/12/2024
  Title: Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network me a-analysis
• Date: 01/10/2024
  Title: Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach
• Date: 01/10/2024
  Title: Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial
• Date: 01/10/2024
  Title: Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score
• Date: 01/06/2024
  Title: Postprocedural anticoagulation after primary percutaneous coronary intervention for st-segment–elevation myocardial infarction: a multicenter, randomized, double-blind trial
• Date: 01/06/2024
  Title: Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials
• Date: 01/06/2024
  Title: Low-dose colchicine for atherosclerosis: long-term safety
• Date: 01/04/2024
  Title: Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h
• Date: 01/04/2024
  Title: Efficacy and safety of non–vitamin-k antagonist oral anticoagulants versus warfarin across the spectrum of body mass index and body weight: an individual patient data meta-analysis of 4 randomized clinical trials of patients with atrial fibrillation
• Date: 01/04/2024
  Title: Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials
• Date: 01/02/2024
  Title: Characteristics and outcomes in patients with a prior myocardial infarction treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings from ALETHEIA, a multi-country observational study
• Date: 01/02/2024
  Title: Platelet biology and function: plaque erosion vs. rupture
• Date: 01/02/2024
  Title: Inflammation in acute myocardial infarction: the good, the bad and the ugly
• Date: 01/12/2023
  Title: Factor XIa inhibitors: collecting the clinical evidence
• Date: 01/12/2023
  Title: Anticoagulation with edoxaban in patients with long Atrial High-Rate Episodes ≥24 hours
• Date: 01/12/2023
  Title: Pharmacology and Clinical Development of Factor XI Inhibitors
• Date: 01/04/2023
  Title: Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture
• Date: 01/04/2023
  Title: Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials
• Date: 01/04/2023
  Title: Clinical Evaluation of Factor XIa Inhibitor Drugs: JACC Review Topic of the Week
• Date: 01/02/2023
  Title: Risk factors profile of young and older patients with myocardial infarction
• Date: 01/02/2023
  Title: Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54
• Date: 01/02/2023
  Title: Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial
• Date: 01/04/2022
  Title: Prognostic implications of neutrophil extracellular traps in coronary thrombi of patients with st-elevation myocardial infarction
• Date: 01/04/2022
  Title: Neutrophil extracellular traps in the infarct-related coronary artery—a marker or mediator of adverse outcome?
• Date: 07/01/2022
  Title: Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial
• Date: 13/11/2021
  Title: 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
• Date: 25/04/2021
  Title: 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
• Date: 07/04/2021
  Title: Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
• Date: 25/02/2021
  Title: Severe SARS-CoV-2 infection inhibits fibrinolysis leading to changes in viscoelastic properties of blood clot: A descriptive study of fibrinolysis
• Date: 25/02/2021
  Title: Antibody-induced procoagulant platelets in severe COVID-19 infection
• Date: 12/01/2021
  Title: Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease
• Date: 06/01/2021
  Title: Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model
• Date: 04/01/2021
  Title: COVID-19-related medical research: a meta-research and critical appraisal
• Date: 14/11/2020
  Title: Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
• Date: 27/07/2020
  Title: Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov
• Date: 01/04/2020
  Title: Antithrombotic Therapy for Patients with Left Ventricular Mural Thrombus
• Date: 19/10/2019
  Title: Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy-Current Evidence and Practice
• Date: 01/05/2019
  Title: Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis
• Date: 01/04/2019
  Title: Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation
• Date: 01/04/2019
  Title: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
• Date: 01/04/2019
  Title: A changing landscape: Temporal trends in incidence and characteristics of patients hospitalized with venous thromboembolism 2006-2015
• Date: 01/04/2019
  Title: Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-Study
• Date: 01/04/2019
  Title: Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
• Date: 01/03/2019
  Title: Staphylococcus aureus endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves
• Date: 01/03/2019
  Title: Contractile forces in platelet aggregates under microfluidic shear gradients reflect platelet inhibition and bleeding risk
• Date: 01/02/2019
  Title: Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes
• Date: 01/01/2019
  Title: Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study